CC vs. HUN, ASH, BCPC, IOSP, NGVT, HWKN, OLN, PRM, FMC, and AMR
Should you be buying Chemours stock or one of its competitors? The main competitors of Chemours include Huntsman (HUN), Ashland (ASH), Balchem (BCPC), Innospec (IOSP), Ingevity (NGVT), Hawkins (HWKN), Olin (OLN), Perimeter Solutions (PRM), FMC (FMC), and Alpha Metallurgical Resources (AMR). These companies are all part of the "basic materials" sector.
Huntsman (NYSE:HUN) and Chemours (NYSE:CC) are both mid-cap basic materials companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, community ranking, institutional ownership, dividends, risk, profitability, media sentiment and valuation.
Huntsman has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500. Comparatively, Chemours has a beta of 2, indicating that its stock price is 100% more volatile than the S&P 500.
84.8% of Huntsman shares are owned by institutional investors. Comparatively, 76.3% of Chemours shares are owned by institutional investors. 6.1% of Huntsman shares are owned by insiders. Comparatively, 1.6% of Chemours shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Chemours received 7 more outperform votes than Huntsman when rated by MarketBeat users. However, 66.56% of users gave Huntsman an outperform vote while only 61.01% of users gave Chemours an outperform vote.
Huntsman pays an annual dividend of $1.00 per share and has a dividend yield of 4.2%. Chemours pays an annual dividend of $1.00 per share and has a dividend yield of 3.8%. Huntsman pays out 188.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Chemours pays out -64.5% of its earnings in the form of a dividend. Huntsman has raised its dividend for 4 consecutive years. Huntsman is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Huntsman has a net margin of 1.65% compared to Huntsman's net margin of -3.80%. Huntsman's return on equity of 51.73% beat Chemours' return on equity.
In the previous week, Chemours had 23 more articles in the media than Huntsman. MarketBeat recorded 37 mentions for Chemours and 14 mentions for Huntsman. Chemours' average media sentiment score of 0.20 beat Huntsman's score of 0.02 indicating that Huntsman is being referred to more favorably in the media.
Huntsman presently has a consensus price target of $26.55, suggesting a potential upside of 10.56%. Chemours has a consensus price target of $30.89, suggesting a potential upside of 18.67%. Given Huntsman's stronger consensus rating and higher possible upside, analysts plainly believe Chemours is more favorable than Huntsman.
Huntsman has higher revenue and earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Huntsman, indicating that it is currently the more affordable of the two stocks.
Summary
Huntsman beats Chemours on 13 of the 21 factors compared between the two stocks.
Get Chemours News Delivered to You Automatically
Sign up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Chemours Competitors List
Related Companies and Tools
